Dianthus Therapeutics (DNTH) Receivables - Other: 2018-2024
Historic Receivables - Other for Dianthus Therapeutics (DNTH) over the last 2 years, with Dec 2024 value amounting to $807,000.
- Dianthus Therapeutics' Receivables - Other rose 303.50% to $807,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $807,000, marking a year-over-year increase of 303.50%. This contributed to the annual value of $807,000 for FY2024, which is 303.50% up from last year.
- Latest data reveals that Dianthus Therapeutics reported Receivables - Other of $807,000 as of Q4 2024, which was down 37.92% from $1.3 million recorded in Q3 2024.
- Dianthus Therapeutics' Receivables - Other's 5-year high stood at $1.3 million during Q3 2024, with a 5-year trough of $200,000 in Q4 2023.
- For the 3-year period, Dianthus Therapeutics' Receivables - Other averaged around $703,714, with its median value being $800,000 (2024).
- Per our database at Business Quant, Dianthus Therapeutics' Receivables - Other tumbled by 77.78% in 2023 and then soared by 303.50% in 2024.
- Over the past 3 years, Dianthus Therapeutics' Receivables - Other (Quarterly) stood at $900,000 in 2022, then crashed by 77.78% to $200,000 in 2023, then soared by 303.50% to $807,000 in 2024.
- Its Receivables - Other stands at $807,000 for Q4 2024, versus $1.3 million for Q3 2024 and $800,000 for Q2 2024.